Although half of the world’s population does not drink, alcohol use is the seventh leading risk factor for both deaths and disability-adjusted life years globally, and the leading risk factor among those aged 15–49 years. Alcohol is a modifiable risk factor; reductions in alcohol consumption would lead to an associated reduction in the burden of […]
People who are homeless have complex and challenging lives. They tend to have worse physical and mental health, and are more likely to report problem substance use, than the general population. Substance use is more prevalent among people who are homeless than in the general population, and providing support services and drug treatment in a […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
Housing with support is purpose-built, non-institutional accommodation where older people have their own front door and where support or care services are available. The implementation of housing with support for older people is rapidly expanding, particularly as life expectancy is increasing throughout the world. This expansion is likely to intensify in the context of coronavirus […]
The HRB Strategy 2021–2025, Health research – making an impact, is a five-year strategic plan that defines the aims, activities and outcomes of the organisation at a high level. Developed following a process of extensive engagement with stakeholders, together with input from an International Expert Advisory Panel, the strategy sets out a clear direction for the HRB […]
This summary publication gives a rapid overview of the HRB Strategy 2021–2025, Health research – making an impact: the HRB’s five-year strategic plan that defines the aims, activities and outcomes of the organisation at a high level. Developed following a process of extensive engagement with stakeholders, together with input from an International Expert Advisory Panel, the strategy sets out […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
This systematic evidence review assessed the efficacy and safety of electronic cigarettes (e-cigarettes) and heat-not-burn products in helping people who smoke to achieve abstinence at 24 or 26 and 52 weeks using randomised controlled trials (RCTs). Seven RCTs met the inclusion criteria for efficacy of e-cigarettes in helping people quit smoking and nine provided data […]
This mapping exercise describes the nature and extent of the peer-reviewed literature on the public health harms and benefits of e-cigarettes and heat-not-burn tobacco products to the human population. The authors identified 388 papers eligible for inclusion in the map, 361 reporting the harms and benefits of e-cigarettes, and 28 reporting the harms and benefits […]
This systematic review of longitudinal cohort studies aimed to explore whether electronic cigarette (e-cigarette) use by adolescents in Europe and North America, who had never smoked conventional tobacco cigarettes (tobacco cigarettes) at baseline, was associated with subsequent initiation of tobacco cigarette smoking. Nine of the 14 unique longitudinal studies with follow-up periods between 4 and 24 […]
This bulletin, along with the two supplementary bulletins, presents the inaugural findings of data from the National Ability Supports System (NASS). It provides a profile of the 22,434 people with a disability registered on the system in 2019 as well as details of the disability-funded services currently availed of and those required in the next […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
Contents include: Chairperson and Chief Executive’s report; Snapshot of HRB activities during 2019; Key deliverables in line with HRB strategy 2016 – 2020; and Appendices. The Corporate Governance and Financial Statements were published in a Part 2 on 28 December 2020 following approval of the financial statements by the Office of the Comptroller and Auditor General, […]
This is the annually updated bulletin from the National Drug Treatment Reporting System (NDTRS) on cases of treated problem alcohol use in Ireland. It covers the period 2013 to 2019. In this seven-year period 53,200 cases were treated for alcohol as a main problem drug.
The 2019 report provides data presented nationally as well as: * CHO * county * hospital type * individual psychiatric units/hospitals
The aim of this evidence review was to identify countries that had implemented new overarching public health legislation for infectious diseases, to identify the legislation they enacted, and to identify lessons learned from national experiences of introducing new legislation. This evidence review was designed as a systematic review. Fourteen jurisdictions were eligible for inclusion. Overall, […]
This is the annually updated bulletin from the National Drug Treatment Reporting System (NDTRS) on cases of treated problem drug use (excluding alcohol) in Ireland. It covers the period 2013 to 2019. In this seven-year period, 67,875 cases were treated for drug use as a main problem.
International binding agreements oblige signatories, including Ireland, to reduce their use of mercury to protect the environment. In response, the Irish Government need to phase out the use of dental amalgam by 2030. The aim of this evidence review was to examine factors relevant to phasing out amalgam and consider alternative replacement strategies for treating […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
This report presents findings from the tenth national psychiatric census of patients in psychiatric units and hospitals, the latest in a series of censuses first carried out in 1963. The census is a count of all patients resident in psychiatric units and hospitals operating within the provisions of the Mental Health Act 2001, (Government of […]
Outputs, outcomes and emerging impacts: Results from HRB awards completed in 2016/2017 This report presents a snapshot of, and provides trend analysis over 10 years for, the outputs, outcomes and some emerging impacts from 187 HRB awards (combined value of €47.2 million) that completed in 2016 and 2017. It demonstrates that HRB-funded researchers are highly […]
This update presents figures from the National Drug-Related Deaths Index (NDRDI) on deaths due to poisoning (overdose) by alcohol and/or other drugs, and deaths among people who use drugs which are not due to poisoning (non-poisonings) for the period 2008-2017.
Since 2004, the HRB has invested €37.9 million to support the development of leaders in research in both the academic and clinical environments through the Research Leader Awards in Population Health and Health Services Research (RLA in PHHSR) and the Clinician Scientist Awards (CSA). This evaluation was conducted by the HRB to determine whether these […]
